A Series of 14 Polish Patients with Thrombotic Events and PC Deficiency-Novel c.401-1G>A PROC Gene Splice Site Mutation in a Patient with Aneurysms

• Published in: Genes Vol. 13; no. 5; p. 733
• Main Authors: Weronska, Anna, Potaczek, Daniel P., Oto, Julia, Medina, Pilar, Undas, Anetta, Wypasek, Ewa
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 22.04.2022; MDPI
• Subjects: Administration, Oral; Adult; Aneurysm; Aneurysm - drug therapy; Aneurysms; Anticoagulants; Anticoagulants - therapeutic use; Cardiovascular disease; Exons; Female; Hepatic artery; Humans; Laboratories; Middle Aged; Missense mutation; Mutation; Patients; Plasma; Poland; ProC gene; Protein C; Protein C - genetics; Protein C - metabolism; Protein C - therapeutic use; Protein C Deficiency - drug therapy; Protein C Deficiency - genetics; Protein deficiency; Proteins; Pulmonary embolisms; Stroke; Thromboembolism; Thrombophilia; Thrombosis; Thrombosis - genetics; Poland; United States > US; family study; protein C deficiency; gene mutations; venous thromboembolism
• ISSN: 2073-4425; 2073-4425
• DOI: 10.3390/genes13050733

Objectives: Protein C (PC) deficiency is an inherited thrombophilia with a prevalence of 0.5% in the general population and 3% in subjects with a first-time deep vein thrombosis (DVT). Here we report a series of 14 PC-deficient Polish patients with comprehensive clinical and molecular characteristics, including long-term follow-up data and a deep mutational analysis of the PROC gene. Patients and Methods: Fourteen unrelated probands (mean ± SD age 43.8 ± 13.0 years) with suspicion of PC deficiency, who experienced thromboembolic events and a majority of whom received anticoagulants (92.8%), were screened for PROC mutations by sequencing the nine PROC exons and their flanking intron regions. Results: Ten probands (71.4%) had missense mutations, two patients (14.3%) carried nonsense variants, and the other two subjects (14.3%) had splice-site mutations, the latter including the c.401-1G>A variant, reported here for the very first time. The proband carrying the c.401-1A allele had a hepatic artery aneurysm with a highly positive family history of aneurysms and the absence of any mutations known to predispose to this vascular anomaly. Conclusion: A novel detrimental PROC mutation was identified in a family with aneurysms, which might suggest yet unclear links of thrombophilia to vascular anomalies, including aneurysms at atypical locations in women. The present case series also supports data indicating that novel oral anticoagulants (NOACs) are effective in PC deficient patients.